tiprankstipranks
Trending News
More News >
Bio-Rad Laboratories (BIO)
NYSE:BIO
US Market
Advertisement

Bio-Rad Laboratories (BIO) Income Statement

Compare
906 Followers

Bio-Rad Laboratories Income Statement

Last quarter (Q2 2025), Bio-Rad Laboratories's total revenue was $651.60M, an increase of 2.06% from the same quarter last year. In Q2, Bio-Rad Laboratories's net income was $317.80M. See Bio-Rad Laboratories’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 2.57B$ 2.67B$ 2.80B$ 2.92B$ 2.55B
Gross Profit
$ 1.38B$ 1.43B$ 1.57B$ 1.64B$ 1.44B
Operating Expenses
$ 1.11B$ 1.09B$ 1.08B$ 1.14B$ 1.02B
Depreciation and Amortization
$ 151.60M$ 145.90M$ 177.20M$ 137.60M$ 138.60M
EBITDA
$ -2.14B$ -654.80M$ -4.49B$ 5.59B$ 5.08B
Operating Income
$ 269.00M$ 337.80M$ 482.62M$ 500.34M$ 421.33M
Other Income/Expenses
$ -2.61B$ -1.19B$ -5.19B$ 4.95B$ 4.50B
Pretax Income
$ -2.34B$ -850.10M$ -4.70B$ 5.45B$ 4.92B
Net Income
$ -1.84B$ -637.32M$ -3.63B$ 4.25B$ 3.81B
Per Share Metrics
Basic EPS
$ -65.36$ -21.82$ -121.79$ 142.61$ 127.86
Diluted EPS
$ -65.36$ -21.82$ -121.79$ 140.83$ 126.20
Weighted Average Shares Outstanding
28.21M 29.21M 29.79M 29.83M 29.77M
Weighted Average Shares Outstanding (Diluted)
28.21M 29.21M 29.79M 30.21M 30.16M
Currency in USD

Bio-Rad Laboratories Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis